960289-28-5 Usage
Uses
Used in Pharmaceutical Research:
1-(5-bromopyridin-2-yl)-N,N-dimethylpiperidine-4-amine is used as a chemical intermediate for the development of therapeutic drugs, leveraging its potential pharmacological properties to address various medical conditions. Its unique structure allows for further modification and optimization to enhance its therapeutic effects and safety profile.
Used in Drug Design and Synthesis:
In the field of medicinal chemistry, 1-(5-bromopyridin-2-yl)-N,N-dimethylpiperidine-4-amine serves as a key building block for designing and synthesizing novel drug candidates. Its versatile structure can be modified to create a range of compounds with improved pharmacokinetic and pharmacodynamic properties, ultimately leading to more effective treatments for patients.
Used in Neuropharmacology:
Given its structural similarity to certain neurotransmitters and receptor modulators, 1-(5-bromopyridin-2-yl)-N,N-dimethylpiperidine-4-amine may be used as a research tool in neuropharmacology to study the interactions between drugs and the central nervous system. This could lead to the development of new treatments for neurological and psychiatric disorders.
Used in Chemical Synthesis and Material Science:
Beyond its pharmaceutical applications, 1-(5-bromopyridin-2-yl)-N,N-dimethylpiperidine-4-amine may also find use in other areas of chemical synthesis and material science. Its unique functional groups and structural features could be exploited to create new materials with specific properties, such as improved conductivity, stability, or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 960289-28-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,6,0,2,8 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 960289-28:
(8*9)+(7*6)+(6*0)+(5*2)+(4*8)+(3*9)+(2*2)+(1*8)=195
195 % 10 = 5
So 960289-28-5 is a valid CAS Registry Number.
960289-28-5Relevant academic research and scientific papers
Novel EZH2 inhibitor and application thereof
-
Paragraph 0158; 0160; 0167; 0168, (2018/08/03)
The invention relates to an inhibitor for a wild type of human histone methyltransferase EZH2 and a mutation type of Y641, and the inhibitor is of a structure of formula (I) as shown in the specification. The invention further provides a method and application for treatment cancer or pre-cancerous diseases related to activity of EZH2 with the inhibitor.
PYRAZOLOPYRIMIDIN-2-YL DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 95; 97, (2015/06/25)
New pyrazolopyridmiin-2-yl derivatives are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).
FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS
-
Page/Page column 81, (2009/08/14)
Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of CDK4 mediated disorders, such as cancer. The subject compounds are fused pyridine, pyrimide and triazine derivatives.
NOVEL MCH RECEPTOR ANTAGONISTS
-
Page/Page column 31-32, (2008/06/13)
The present invention relates to a melanin concentrating hormone antagonist compound of formula (I): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.
